Top Markets
Coin of the day
Mirati Therapeutics, Inc. Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc.

MRTX
Classement en actions #5115
Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the... Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the clinical stage, committed to identifying and developing treatments that target the genetic and immunological factors driving cancer progression. Its pipeline features MRTX849, a KRAS G12C inhibitor currently undergoing Phase 1/2 clinical trials for a range of malignancies, including non-small cell lung, colorectal, and pancreatic cancers. Additionally, the company is advancing Sitravatinib, an investigational broad-spectrum kinase inhibitor, which has reached Phase 3 clinical trials specifically for non-small cell lung cancer. Mirati also has a KRAS G12D inhibitor program in its preclinical development phase. The company has forged a collaboration and licensing agreement with BeiGene, Ltd. for the development, manufacturing, and commercialization of sitravatinib. Established in 1995, Mirati Therapeutics, Inc. maintains its headquarters in San Diego, California.
Prix de l'action
$58.70
Dernière synchronisation: 2024-01-23
Capitalisation boursière
$2.98B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Mirati Therapeutics, Inc. (MRTX)

Catégorie

Historique des divisions d’actions pour Mirati Therapeutics, Inc. (MRTX)
L’action Mirati Therapeutics, Inc. (symbole : MRTX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 27, 2026.
Une action MRTX achetée avant le Aug 27, 2026 équivaudrait aujourd’hui à 0 actions MRTX.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH